HPTN 094 or “INTEGRA Houston” is a vanguard study to determine the effectiveness of using a mobile health unit to provide integrated health services – particularly medication for opioid use disorder (OUD) and medication for HIV treatment or prevention – to people with OUD who inject drugs in five U.S. cities.